pregnancy on tirzepatide and Pregnancy: Safety Facts Why should pregnancy be avoided

and orforglipron, an oral nonpeptide GLP-1 receptor agonist

They also explain why the regulatory landscape became so contentious

This includes individuals with a personal or family history of medullary thyroid carcinoma, those with Multiple Endocrine Neoplasia syndrome type 2, patients with type 1 diabetes or diabetic ketoacidosis, anyone currently taking another GLP-1 receptor agonist medication, pregnant or breastfeeding individuals, and patients with active pancreatitis

Hormonal changes Shedding the pounds can disrupt the balance of your hormones, and these shifts can interrupt the hair growth cycle , increasing the rate at which your hair sheds

The FDA determined the injectable tirzepatide shortage resolved in late 2024